Zynlonta 79952-0110-01

Generic: Loncastuximab Tesirine

Package NDC

79952-0110-01

Manufacturer: Adc Therapeutics America, Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: April 30, 2021
Listing Expires: December 31, 2027
Application: BLA761196

Need to source Zynlonta? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Loncastuximab Tesirine	10 mg/2mL

Selected Package

79952-0110-01Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (79952-110-01) / 2 mL in 1 VIAL, SINGLE-DOSE